-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NK7vO4YgQo+gbzsWloXilPUYbLzdfUQXfGubB+uDQ08YdzudvHwGPNOv1hgcxA60 KcltgLaqXRaHZBeIa95zWg== 0001193125-07-000774.txt : 20070103 0001193125-07-000774.hdr.sgml : 20070101 20070103164015 ACCESSION NUMBER: 0001193125-07-000774 CONFORMED SUBMISSION TYPE: 25 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070103 DATE AS OF CHANGE: 20070103 EFFECTIVENESS DATE: 20070103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 07505233 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 25 1 d25.htm FORM 25 Form 25
   

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 25

  OMB APPROVAL
   

OMB Number: 3235-0080

Expires: February 28, 2009

Estimated average burden hours per response . . . . .1.00

NOTIFICATION OF REMOVAL FROM LISTING AND/OR

REGISTRATION UNDER SECTION 12(b) OF THE

SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 1-1136

 

 

Bristol-Myers Squibb Company; Delisting from NYSE Arca, Inc. (formerly Pacific Exchange, Inc.)
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
345 Park Avenue, New York, New York 10154; 212-546-4000
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
Common Stock, $0.10 Par Value, and $2 Convertible Preferred Stock, $1 Par Value
(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

 

¨ 17 CFR 240.12d2-2(a)(1)

 

¨ 17 CFR 240.12d2-2(a)(2)

 

¨ 17 CFR 240.12d2-2(a)(3)

 

¨ 17 CFR 240.12d2-2(a)4

¨ Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.1

x Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements of the Securities Exchange Act of 1934, Bristol-Myers Squibb Company (Name of Issuer or Exchange) certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

 

Dated:   January 3, 2007     BRISTOL-MYERS SQUIBB COMPANY
      By:      /s/ Sandra Leung
      Name:      Sandra Leung
      Title:      Secretary

1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

 

SEC 1654(03-06)    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
-----END PRIVACY-ENHANCED MESSAGE-----